Sophia Abene

Insights from the Annual Conference on Vaccinology Research (ACVR) on vaccine registries and assessing the safety of maternal and fetal health.

Investigating the long-term efficacy beyond short-term benefits.

Despite overall reductions, the elderly remain vulnerable to severe COVID-19 outcomes.

The Department of Agriculture has initiated proactive measures, collaborating with federal agencies, to ensure the safety of the nation's meat supply.

This week, April FDA roundup, ESCMID conference coverage, enhancing C difficile treatment, and more from Contagion.

Despite no reported cases of illness associated with the affected products, all retailers who received these items have been duly informed, and the recall is being conducted in coordination with the FDA.

Detection of E coli bacteria and inorganic arsenic in these products raises significant health concerns.

This study monitored viral load in asymptomatic blood donors, unveiling insights into the progression of HEV infections, vital for public health strategies.

Study reveals concerning trends from the mosquito-borne disease impacting Canada and the US.

The Food and Drug Administration (FDA) in collaboration with the Centers for Disease Control and Prevention (CDC) and state and local health partners, are investigating a multistate outbreak of E coli O157:H7 infections linked to organic walnuts.

Insights from Dr. Md Zahidul Alam on treatments and prevention strategies for C difficile infection (CDI), supported by the CDC's recent study on CDI management in healthcare settings.

A study presented at ESCMID examines the efficacy and safety of the vaccine in older populations.

FDA-approves mpox vaccine, FDA grants EUA for at-home multiplex papid test, FDA grants PDUFA for GSK 5-in-1 meningococcal vaccine, and more this month from the FDA.

A study presented at ESCMID aims to understand ribotype 955 as a new challenge in C difficile management.

C-SMART trial results presented at ESCMID show a reduction of COVID-19 incidence in cancer patients.

Insights into host-directed therapies (HDT) for tuberculosis (TB) gaining traction among experts aiming to combat the disease's various forms, including drug-resistant strains.

Insights from Pranay Sinna MD on a multicenter prospective cohort study on household contacts.

In a collaboration between the University of Oxford, the Ministry of Health in Rwanda, and the Rwanda Biomedical Centre, groundbreaking data on the R21/Matrix-M malaria vaccine, marks a significant shift in the malaria paradigm.

Photini Sinnis MD, professor at the Johns Hopkins School of Public Health and Deputy Director of the Johns Hopkins Malaria Research Institute, offers her expert insights into this zoonotic disease.

Study from the Journal of Hepatology aims to characterize immune responses associated with rapid natural clearance of HCV reinfection.

FDA recalls, allergy alerts, e coli & salmonella outbreaks, and more.

Already FDA-approved in the US, TG-1000 confirms safety and prepares for global expansion.

Evaluating inpatient mortality for patients without supplemental oxygen at admission across different variants of concern periods with insights from Dr. Andre Kalil.

Monika Pogorzelska-Maziarz, epidemiologist, health services researcher, and associate professor at Thomas Jefferson University, shares insights on COVID-19's influence in acute care hospitals at this year’s Society for Healthcare Epidemiology of America (SHEA) conference.

Study by the Centers for Disease Control and Prevention (CDC) explores future directions for pediatric COVID-19 vaccination amid emerging variants.

The New York City Department of Health and Mental Hygiene reports a record amount of Leptospirosis cases, the zoonotic disease, from rat urine.

Study highlighting the first documented case of C auris moving from adult to pediatric unit in Maryland, COVID-19 physical health problems lingering 1 year after their hospital stay, 5-in-1 meningococcal vaccine given FDA PDUFA, and more this week from Contagion.

Trader Joe’s pulls contaminated organic basil after multi-state illnesses were reported.

A study presented at the Society for Healthcare Epidemiology of America (SHEA) conference assesses the link between antibiotic use and C difficile infection in Tennessee.

Men5CV is expected to target 5 strains of the meningococcus bacteria, reducing meningitis cases across the region.